Actor Milana Vayntrub, perhaps best known as Lily from her AT&T commercials, has made her mark in show business. However, she ...

Allen touched on her husband David Harbour's reaction to her selling pictures of her feet online. "Yeah, he is, he thinks i ...

Lily Allen is making a bold claim about the income she makes from selling pictures of her feet on OnlyFans. The "Smile" ...

Lily Ford is THR’s U.K. Reporter, covering breaking news, features, award shows, premieres and the like from across the pond in London. She came to THR from ITV News as a multimedia producer and ...

WIRED is where tomorrow is realized. It is the essential source of information and ideas that make sense of a world in constant transformation. The WIRED conversation illuminates how technology is ...

Eli Lilly said Wednesday it will invest $4.5 billion to build an advanced pharmaceutical drug manufacturing and development facility in Lebanon, Indiana expected to open in late 2027. Fatty liver ...

Eli Lilly (NYSE:LLY) is reportedly looking to study its popular weight-loss drug Zepbound in people who aren't considered overweight but are still at risk for developing conditions such as diabetes.

The board of directors of Eli Lilly and Company (NYSE: LLY) has declared a dividend for the fourth quarter of 2024 of $1.30 per share on outstanding common stock. Eli Lilly and Company (NYSE ...

"That was the original intention but the world wasn't quite ready," says Lilly Wachowski ... always living in a world of imagination". Getty Images Keanu Reeves and Carrie-Anne Moss are back ...

The Nikon Comedy Wildlife Awards recognize the funniest images in wildlife photography. The 2024 contest benefits the Whitley Fund for Nature, a wildlife conservation charity. Photos show bears, ...

LEBANON, Ind. (WISH) — Indianapolis-based pharmaceutical giant Lilly on Wednesday announced another billion-dollar project coming to Boone County. The project will be in the LEAP Research and ...

Eli Lilly has finally made enough supply of its popular medicine tirzepatide to meet soaring demand, which should help the company widen its share of the booming weight-loss drug market.